Early Results of Simultaneous Integrated Boost Volumetric Modulated arc Therapy (SIB-VMAT) Combined with Temozolomide in the Postoperative Treatment of Grade 4 glioblastoma
Introduction. Glioblastoma refers to a neuroepithelial malignant brain tumor with an aggressive course and extremely unfavorable prognosis. The median overall survival comprises 14.6 months. Standard treatment demonstrates relatively poor efficiency due to high recurrence rate associated with the hi...
Spremljeno u:
| Glavni autori: | , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Bashkir State Medical University
2024-07-01
|
| Serija: | Креативная хирургия и онкология |
| Teme: | |
| Online pristup: | https://www.surgonco.ru/jour/article/view/951 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|